602P COLUMBUS 7-Year Update: A Randomized, Open-Label, Phase III Trial of Encorafenib (enco) + Binimetinib (bini) Vs Vemurafenib (vemu) or Enco in Patients (pts) with BRAF V600-mutant Melanoma
Annals of Oncology(2023)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined